These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29521127)

  • 1. BAG-S53P4 as bone graft extender and antimicrobial activity against gentamicin- and vancomycin-resistant bacteria.
    Bortolin M; Romanò CL; Bidossi A; Vecchi E; Mattina R; Drago L
    Future Microbiol; 2018 Apr; 13():525-533. PubMed ID: 29521127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection.
    Cunha MT; Murça MA; Nigro S; Klautau GB; Salles MJC
    BMC Infect Dis; 2018 Apr; 18(1):157. PubMed ID: 29614973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro antibacterial effect of S53P4 bioactive glass and gentamicin impregnated polymethylmethacrylate beads.
    Gergely I; Zazgyva A; Man A; Zuh SG; Pop TS
    Acta Microbiol Immunol Hung; 2014 Jun; 61(2):145-60. PubMed ID: 24939683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of bioactive glass S53P4 against representative microorganisms causing osteomyelitis - Real-time assessment by isothermal microcalorimetry.
    Gonzalez Moreno M; Butini ME; Maiolo EM; Sessa L; Trampuz A
    Colloids Surf B Biointerfaces; 2020 May; 189():110853. PubMed ID: 32058256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity and resistance selection of different bioglass S53P4 formulations against multidrug resistant strains.
    Drago L; De Vecchi E; Bortolin M; Toscano M; Mattina R; Romanò CL
    Future Microbiol; 2015; 10(8):1293-9. PubMed ID: 26228640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of different bioactive glass S53P4 formulations in biofilm eradication and the impact of pH and osmotic pressure.
    Müller N; Kollert M; Trampuz A; Gonzalez Moreno M
    Colloids Surf B Biointerfaces; 2024 Jul; 239():113940. PubMed ID: 38744081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study.
    Drago L; Romanò D; De Vecchi E; Vassena C; Logoluso N; Mattina R; Romanò CL
    BMC Infect Dis; 2013 Dec; 13():584. PubMed ID: 24325278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenic protein expression and bone formation are induced by bioactive glass S53P4 scaffolds in vivo.
    Björkenheim R; Strömberg G; Ainola M; Uppstu P; Aalto-Setälä L; Hupa L; Pajarinen J; Lindfors NC
    J Biomed Mater Res B Appl Biomater; 2019 Apr; 107(3):847-857. PubMed ID: 30194906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro.
    Coraça-Huber DC; Fille M; Hausdorfer J; Putzer D; Nogler M
    J Orthop Res; 2014 Jan; 32(1):175-7. PubMed ID: 24108602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiofilm agents against MDR bacterial strains: is bioactive glass BAG-S53P4 also effective?
    Bortolin M; De Vecchi E; Romanò CL; Toscano M; Mattina R; Drago L
    J Antimicrob Chemother; 2016 Jan; 71(1):123-7. PubMed ID: 26462989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions - a Retrospective Study of 50 Patients.
    Malat TA; Glombitza M; Dahmen J; Hax PM; Steinhausen E
    Z Orthop Unfall; 2018 Apr; 156(2):152-159. PubMed ID: 29665602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical applications of Bioactive glass S53P4 in bone infections: a systematic review.
    Bigoni M; Turati M; Zanchi N; Lombardo AS; Graci J; Omeljaniuk RJ; Zatti G; Gaddi D
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(2 Suppl):240-251. PubMed ID: 30977891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
    Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis.
    Lindfors NC; Hyvönen P; Nyyssönen M; Kirjavainen M; Kankare J; Gullichsen E; Salo J
    Bone; 2010 Aug; 47(2):212-8. PubMed ID: 20624692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilisation of bioactive glass S53P4 inside an induced membrane for severe bone defect with high risk of infection: a multi-center preliminary experience.
    Aurégan JC; Villain B; Glombitza M; Blokhuis T; Heinänen M; Bégué T
    Injury; 2022 Oct; 53 Suppl 2():S13-S19. PubMed ID: 35871084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the clinical effectiveness of bioactive glass (S53P4) in the treatment of non-unions of the tibia and femur: study protocol of a randomized controlled non-inferiority trial.
    Tanner MC; Heller R; Westhauser F; Miska M; Ferbert T; Fischer C; Gantz S; Schmidmaier G; Haubruck P
    Trials; 2018 May; 19(1):299. PubMed ID: 29843766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro anti-biofilm activity of a biphasic gentamicin-loaded calcium sulfate/hydroxyapatite bone graft substitute.
    Butini ME; Cabric S; Trampuz A; Di Luca M
    Colloids Surf B Biointerfaces; 2018 Jan; 161():252-260. PubMed ID: 29096369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal Activity and Synergy Studies of Peptide AP-CECT7121 Against Multi-resistant Bacteria Isolated from Human and Animal Soft Tissue Infections.
    Delpech G; Bistoletti M; Ceci M; Lissarrague S; Bruni SS; Sparo M
    Probiotics Antimicrob Proteins; 2017 Sep; 9(3):355-362. PubMed ID: 28573492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAG-S53P4 as an additive to bone allografts: A laboratory study using an uniaxial compression test.
    Putzer D; Fuchs J; Coraça-Huber D; Christoph A; Liebensteiner M; Nogler M
    J Orthop Res; 2015 Dec; 33(12):1875-9. PubMed ID: 26016590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dentin enhances the effectiveness of bioactive glass S53P4 against a strain of Enterococcus faecalis.
    Zehnder M; Waltimo T; Sener B; Söderling E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):530-5. PubMed ID: 16545719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.